儿童单纯疱疹病毒性脑炎的预后

Outcome of herpes simplex encephalitis in children.

作者信息

Hsieh Wen Bin, Chiu Nan Chang, Hu Kun Chieh, Ho Che Sheng, Huang Fu Yuan

机构信息

Department of Pediatrics, Mackay Memorial Hospital, Taipei, Taiwan.

出版信息

J Microbiol Immunol Infect. 2007 Feb;40(1):34-8.

DOI:
Abstract

BACKGROUND AND PURPOSE

Herpes simplex encephalitis (HSE) can cause high mortality and morbidity in children. Since local data of HSE in children are rare, we performed a retrospective study to evaluate the prognostic factors and outcome of HSE in Taiwan.

METHODS

Children were enrolled into this study if they were diagnosed as having encephalitis and also had positive polymerase chain reaction for herpes simplex virus (HSV) from cerebrospinal fluid, and/or positive immunoglobulin M or at least four-fold elevation of immunoglobulin G against HSV type 1 or type 2 from serum during the period from December 1, 1984 to January 31, 2003.

RESULTS

Forty patients were enrolled in this study. Twenty six patients (65%) had good outcome and 14 (35%) had poor outcome. No mortality or recurrence was found. Three-fifths of the patients were between 1 year and 6 years of age. Fever (75%) was the most common finding at admission, followed by seizures (63%), lethargy (60%), and altered consciousness (48%). Seizure and lethargy at the time of admission were more common in the poor outcome group (71% vs 58% and 64% vs 58%). Abnormal computed tomography/magnetic resonance imaging findings were found in 63% of patients in whom the examinations were performed. Abnormal electroencephalogram (EEG) findings were noted in 79% of tested patients. Acyclovir was used to treat 29 patients (73%). Abnormal neuroimaging or EEG findings were more prevalent in patients with poor outcome (75% vs 55% and 92% vs 71%), as well as delayed (>/=3 days) initiation of acyclovir therapy (92% vs 71%). There was no significant difference between the poor and good outcome groups in gender, age distribution, and clinical presentation.

CONCLUSION

As we cannot predict the outcome of patients with HSE in the early beginning of illness and delay of treatment may cause disaster, early diagnosis and prompt acyclovir initiation are important requirements for successful management.

摘要

背景与目的

单纯疱疹病毒性脑炎(HSE)可导致儿童高死亡率和高发病率。由于台湾地区儿童HSE的本地数据较少,我们进行了一项回顾性研究,以评估台湾地区儿童HSE的预后因素和结局。

方法

纳入本研究的儿童需满足被诊断为脑炎,且在1984年12月1日至2003年1月31日期间,脑脊液中单纯疱疹病毒(HSV)聚合酶链反应呈阳性,和/或血清中抗1型或2型HSV的免疫球蛋白M呈阳性或免疫球蛋白G至少升高四倍。

结果

本研究共纳入40例患者。26例患者(65%)预后良好,14例(35%)预后不良。未发现死亡或复发情况。五分之三的患者年龄在1岁至6岁之间。发热(75%)是入院时最常见的表现,其次是癫痫发作(63%)、嗜睡(60%)和意识改变(48%)。入院时癫痫发作和嗜睡在预后不良组中更为常见(分别为71%对58%和64%对58%)。63%接受检查的患者计算机断层扫描/磁共振成像结果异常。79%接受检测的患者脑电图(EEG)结果异常。29例患者(73%)使用阿昔洛韦治疗。预后不良的患者中,神经影像学或EEG异常结果更为普遍(分别为75%对55%和92%对71%),以及阿昔洛韦治疗开始延迟(≥3天)的情况也更常见(92%对71%)。预后不良组和预后良好组在性别、年龄分布和临床表现方面无显著差异。

结论

由于在疾病早期我们无法预测HSE患者的结局,且治疗延迟可能导致灾难,因此早期诊断和及时开始使用阿昔洛韦是成功治疗的重要要求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索